Startup profile · funding coverage
Varda Space Industries funding, valuation and investors
Microgravity-enabled life-sciences company manufacturing pharmaceutical materials in orbit and returning them to Earth.
Keep track of Varda Space Industries
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series D
$251M · September 30, 2026
Latest known valuation
$1.6B reported
Series D · September 30, 2026
Total disclosed equity funding
$528M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · El Segundo, California
Investors in latest funding
Lead: Lux Capital , Natural Capital
Other: Founders Fund , Khosla Ventures , General Catalyst
Overview
Varda designs orbital processing spacecraft and hypersonic reentry capsules for pharmaceutical manufacturing in microgravity. It announced a $251 million Series D in September 2026, bringing total capital raised to $598 million.
Why Varda Space Industries is interesting
Varda is testing whether falling launch costs can support a repeatable commercial pharmaceutical-manufacturing business in orbit rather than a one-off space experiment.
Product & use cases
W-Series spacecraft process pharmaceutical materials in low Earth orbit and return them through reusable reentry capsules.
- Pharmaceutical crystallization in microgravity
- Rapid orbital processing missions
- Hypersonic reentry and payload recovery
Key facts
- September 2026: $251M Series D
- $598M total capital raised
- Company plans more than a dozen additional missions through 2028
Funding history (newest first)
Series D
2026-09-30 $251M Valuation: $1.6B reported- Lux Capital (lead)
- Natural Capital (lead)
- Founders Fund (participant)
- Khosla Ventures (participant)
- General Catalyst (participant)
Series C
2025-07-10 $187MSeries B
2024-04-05 $90MInvestors in our directory
Funds linked from Varda Space Industries's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: An integrated orbital-processing and return platform, plus flight heritage from multiple commercial reentry missions.
The business must prove that microgravity formulations create enough clinical and economic value to offset launch, spacecraft, regulatory and recovery costs.
-
Space Forge adjacent
In-space manufacturing platform focused on advanced materials.
-
Redwire adjacent
Provides space infrastructure and manufacturing capabilities.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Varda Space Industries's financing or category context.
FAQs about Varda Space Industries
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.